Overview

This month’s featured guest on “Lean Catalyst” is: Michael Egholm, President & CEO, Standard BioTools (NASDAQ: LAB).

In this dynamic, one-hour interview series, we will bring together like-minded CEOs who have successfully embraced Lean thinking to drive exceptional results. Through captivating conversations, we delve into their remarkable achievements, uncovering the strategies, insights, and practical wisdom that have propelled their organizations forward. Each series features an in-depth interview with a distinguished CEO who has demonstrated extraordinary leadership in leveraging Lean principles. It’s a great opportunity for sharing experiences, strategies, and valuable knowledge that others can apply to their own leadership journeys.

As President and Chief Executive Officer, Dr. Michael Egholm leads Standard BioTools in its mission to unleash its next-generation technologies to help drive innovation in the life science industry. Under his direction, Standard BioTools is expected to grow into a best-in-class solutions partner to biopharmaceutical researchers through the expansion of in-house technologies and future acquisitions.

Michael brings more than 25 years of proven leadership in developing and commercializing innovative technologies that drive success in the discovery and development of biopharmaceuticals. Prior to joining Standard BioTools, he served as the Chief Technology Officer of Danaher Life Sciences as well as the founder and leader of Danaher’s corporate venture fund. During that time, he led Danaher’s Pall Corporation Biopharmaceutical business where he played a central role in redesigning its go-to-market structure, leading to the company’s multibillion-dollar revenue today.